(19)
(11) EP 2 328 555 A2

(12)

(88) Date of publication A3:
14.10.2010

(43) Date of publication:
08.06.2011 Bulletin 2011/23

(21) Application number: 09785003.6

(22) Date of filing: 24.08.2009
(51) International Patent Classification (IPC): 
A61K 9/14(2006.01)
A61K 9/48(2006.01)
A61K 31/426(2006.01)
A61P 35/00(2006.01)
A61K 9/19(2006.01)
A61K 31/337(2006.01)
A61K 45/06(2006.01)
(86) International application number:
PCT/GB2009/002068
(87) International publication number:
WO 2010/020799 (25.02.2010 Gazette 2010/08)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated Extension States:
AL BA RS

(30) Priority: 22.08.2008 WO PCT/GB2008/002854

(71) Applicants:
  • Slotervaart Participaties BV
    1066 EC Amsterdam (NL)
  • Stichting Het Nederlands Kanker Instituut
    1066 CX Amsterdam (NL)

(72) Inventors:
  • BEIJNEN, Jacob, Hendrik
    NL-1066 EC Amsterdam (NL)
  • SCHELLENS, Johannes, Henricus, Matthias
    NL-1066 CX Amsterdam (NL)
  • MOES, Johannes
    NL-1066 EC Amsterdam (NL)
  • NUIJEN, Bastiaan
    NL-1066 EC Amsterdam (NL)

(74) Representative: Wilson, Justin Scott et al
Withers & Rogers LLP Goldings House 2 Hays Lane
London SE1 2HW
London SE1 2HW (GB)

   


(54) COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC DISEASES